These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
337 related items for PubMed ID: 20552882
1. [NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated]. MMW Fortschr Med; 2010 May 20; 152(20):46-7. PubMed ID: 20552882 [No Abstract] [Full Text] [Related]
2. Selective COX-2 inhibitors: a promise unfulfilled? Henry D, McGettigan P. Gastroenterology; 2007 Feb 20; 132(2):790-4. PubMed ID: 17261306 [No Abstract] [Full Text] [Related]
3. [Coxib instead of NSAID plus gastric acid inhibitor. Protection for the small intestine]. MMW Fortschr Med; 2004 Mar 25; 146(13):61. PubMed ID: 15219139 [No Abstract] [Full Text] [Related]
7. [3 questions about gastrointestinal risk. Are coxibs here clearly better than NSAID?]]. Krüger K. MMW Fortschr Med; 2006 Nov 30; 148(48):12. PubMed ID: 17615761 [No Abstract] [Full Text] [Related]
11. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Ray WA, Chung CP, Stein CM, Smalley WE, Hall K, Arbogast PG, Griffin MR. Gastroenterology; 2007 Sep 31; 133(3):790-8. PubMed ID: 17854591 [Abstract] [Full Text] [Related]
12. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK. Am J Med; 2005 Nov 31; 118(11):1271-8. PubMed ID: 16271912 [Abstract] [Full Text] [Related]
15. [Coronary risks with NSAID and coxibs. The end of hysteria]. Einecke D. MMW Fortschr Med; 2006 Nov 30; 148(48):10, 12. PubMed ID: 17615760 [No Abstract] [Full Text] [Related]